Health TrialsbyHealthPanel

Robotic Right Hemicolectomy Versus Laparoscopic Right Hemicolectomy

ConditionsColorectal NeoplasmsColorectal Neoplasms MalignantColorectal Neoplasms, BenignColorectal CancerColorectal PolypColorectal AdenomaColorectal Adenocarcinoma
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorJeremy Meyer

About this trial

Robotic right hemicolectomy with intra-corporeal anastomosis may have better short-term recovery outcomes and decreased incidence of incisional hernia when compared to the laparoscopic actual standard of care, for similar safety outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult patients requiring elective minimally invasive RHC for cT1-T3 Nx M0 cancer of the right colon (including cancer of the appendix, caecum, ascending colon and hepatic flexure).

Disqualifiers

Not scheduled for minimally invasive RHC (refuses surgery and/or planned open approach)

Emergency surgery

Hereditary colorectal cancer

Inflammatory bowel disease

Trial design

Design model

Parallel

Treatments tested in this trial

  • Robotic right hemicolectomy

    Procedure/Surgery

    Robotic right hemicolectomy with intracorporeal anastomosis and extraction through a C-section, using the Da Vinci Xi.

  • Laparoscopic right hemicolectomy

    Procedure/Surgery

    Laparoscopic right hemicolectomy with extracorporeal anastomosis and extraction through midline.

Treatment groups

70 Participants
are divided into 2 treatment groups
Group A: Robotic right hemicolectomyExperimental treatment 1 intervention
Group B: Laparoscopic right hemicolectomyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Time to first passage of faeces

Measured in hours, starting at the skin closure of the index surgery

Time frame
From index surgical procedure (skin closure) until time of first passage of faeces, during hospitalisation, on average during the first 7 post-operative days

Secondary outcomes

1

Duration of surgery

Measured in minutes

Time frame
From skin incision to skin closure, during index surgical procedure
2

Blood loss

Measured in ml

Time frame
From skin incision to skin closure, during index surgical procedure
3

Intra-operative transfusion

Number of patients who received blood and/or blood products transfusion

Time frame
From skin incision to skin closure, during index surgical procedure
4

Intra-operative complication

Number of patients who experienced a complication during the index surgery

Time frame
From skin incision to skin closure, during index surgical procedure

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Jeremy Meyer

Lead sponsor

University Hospital, Geneva

Sponsor institution

University Hospital, Geneva

Collaborator

Spital Biel, Switzerland

Collaborator

Hôpital Fribourgeois

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: